Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016:2016:6132640.
doi: 10.1155/2016/6132640. Epub 2016 Jul 31.

Early Esophageal Cancer Specific Survival Is Unaffected by Anatomical Location of Tumor: A Population-Based Study

Affiliations

Early Esophageal Cancer Specific Survival Is Unaffected by Anatomical Location of Tumor: A Population-Based Study

Rajan N Amin et al. Can J Gastroenterol Hepatol. 2016.

Abstract

Background. Approximately one-fifth of all esophageal cancer cases are defined as early esophageal cancer (EEC). Although endoscopic therapy (ET) has been shown to be equally effective as esophagectomy (EST) in patients with EEC, there is little information comparing the survival outcomes of the two therapies based on anatomical location. Methods. A population-based study was conducted and the data was obtained from Surveillance, Epidemiology, and End Results program. Patients with EEC (i.e., stages Tis and T1a) and treated with either ET or EST were analyzed to compare EEC-related survival for three different locations of tumor. Results. The overall EEC-specific 1-year and 5-year mean (±SE) survival rates were 11.66 ± 0.05 and 52.80 ± 0.58 months, respectively. Tumors located in lower third had better 5-year survival compared to those located in middle third (83.50% versus 73.10%, p < 0.01). However, when adjusted for age, race, gender, marital status, grade, stage of tumor, histological type, and treatment modality, there was no significant difference. Conclusion. The EEC-specific 1-year or 5-year adjusted survival did not differ by anatomic location of the tumor. Therefore, ET might serve as a minimally invasive yet effective alternative to EST to treat EEC.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Upper one-third EEC-related survival based on treatment.
Figure 2
Figure 2
Middle one-third EEC-related survival based on treatment.
Figure 3
Figure 3
Lower one-third EEC-related survival based on treatment.

References

    1. Ferlay J., Soerjomataram I., Dikshit R., et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer. 2015;136(5):E359–E386. doi: 10.1002/ijc.29210. - DOI - PubMed
    1. Siegel R. L., Miller K. D., Jemal A. Cancer statistics, 2015. CA—A Cancer Journal for Clinicians. 2015;65(1):5–29. doi: 10.3322/caac.21254. - DOI - PubMed
    1. Howlader N., Noone A. M., Krapcho M., et al. SEER Cancer Statistics Review, 1975–2012. Bethesda, Md, USA: National Cancer Institute; 2015.
    1. Das A., Singh V., Fleischer D. E., Sharma V. K. A comparison of endoscopic treatment and surgery in early esophageal cancer: an analysis of surveillance epidemiology and end results data. American Journal of Gastroenterology. 2008;103(6):1340–1345. doi: 10.1111/j.1572-0241.2008.01889.x. - DOI - PubMed
    1. Wani S., Drahos J., Cook M. B., et al. Comparison of endoscopic therapies and surgical resection in patients with early esophageal cancer: a population-based study. Gastrointestinal Endoscopy. 2014;79(2):224–232. doi: 10.1016/j.gie.2013.08.002. - DOI - PMC - PubMed